Philippines - English - FDA (Food And Drug Administration)

n/a; importer: sanofi pasteur, inc.; distributor: sanofi pasteur, inc. - meningococcal (groups a, polysaccharide diphtheria toxoid conjugate vaccine - solution for im injection - 4mcg; 4mcg; 4mcg; 4mcg; 48mcg

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: sanofi pasteur, inc.; distributor: sanofi pasteur, inc. - quadrivalent seasonal influenza vaccine (split virion, inactivated) 2023 southern hemisphere strain - suspension for injection (im) - formulation: each dose (0.5 ml) contains the following influenza strains*: a/sydney/5/2021 (h1n1) pdm09-like virus (a/sydney/5/2021, san-013) 15 μg of ha** a/darwin/9/2021 (h3n2)-like virus (a/darwin/9/2021, ivr-228) 15 μg of ha** b/austria/1359417/2021 (b/victoria lineage)-like virus (b/michigan/01/2021, wild type) 15 μg of ha** b/phuket/3073/2013 (b/yamagata lineage)-like virus (b/phuket/3073/2013, wild type) 15 μg of ha** *propagated in fertilized hen's eggs from healthy chicken flocks **haemagglutinin

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: sanofi pasteur, inc.; distributor: sanofi pasteur, inc. - quadrivalent seasonal influenza vaccine (split virion, inactivated) 2023 southern hemisphere strain - suspension for injection (im) - formulation: each dose (0.5 ml) contains: a/victoria/2570/2019 ivr-215(hini)-15 mcg* a/darwin/9/2021 san-010 (h3n2)-15 mcg*

European Union - English - EMA (European Medicines Agency)

sanofi pasteur msd, snc - purified diphtheria toxoid, purified tetanus toxoid, purified pertussis toxoid, purified pertussis filamentous haemagglutinin, hepatitis b surface antigen, inactivated type 1 poliovirus (mahoney), inactivated type 2 poliovirus (mef 1), inactivated type 3 poliovirus (saukett), haemophilus influenzae type b polysaccharide - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; poliomyelitis; diphtheria - vaccines - this combined vaccine is indicated for primary and booster vaccination of children against diphtheria, tetanus, pertussis, hepatitis b caused by all known subtypes of viruses, poliomyelitis and invasive infections caused by haemophilus influenzae type b.

Malta - English - Medicines Authority

sanofi pasteur 14 espace henry vallée , 69007 lyon, france - tetanus toxoid - suspension for injection - tetanus toxoid 40 iu - vaccines

Malta - English - Medicines Authority

sanofi pasteur 14 espace henry vallée , 69007 lyon, france - tetanus toxoid, diphtheria toxoid, haemophilus type, b polysaccharide, polyribosylribitol phosphate, conjugated to, as carrier, protein, bordetella pertussis - powder and suspension for suspension for injection - diphtheria toxoid haemophilus type b polysaccharide (polyribosylribitol phosphate) conjugated to tetanus toxoid as carrier protein 10 µg bordetella pertussis 4 iu tetanus toxoid 60 iu - vaccines

Malta - English - Medicines Authority

sanofi pasteur 14 espace henry vallée , 69007 lyon, france - influenza vaccine, split virion, inactivated - suspension for injection - influenza vaccine (split virion, inactivated) 15 µg - vaccines

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi pasteur msd ltd - rabies vaccine - suspension for injection - 2.5 iu/ml - rabies vaccines

European Union - English - EMA (European Medicines Agency)

sanofi winthrop industrie - insulin lispro - diabetes mellitus - drugs used in diabetes - for the treatment of adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. insulin lispro sanofi is also indicated for the initial stabilisation of diabetes mellitus.

European Union - English - EMA (European Medicines Agency)

sanofi winthrop industrie - insulin aspart - diabetes mellitus - drugs used in diabetes - insulin aspart sanofi is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.